| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 11 buys and 6 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | Misra Tushar | SVP, CMO | Sale+OE | 458 | $5.74 | $2,628.92 | -7.2% | |
| Jan 17, 2023 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Off. | Sale+OE | 6,233 | $5.74 | $35,777.42 | -3.3% | |
| Jan 17, 2023 | Deschuytner Brian | SVP, Chief Financial Officer | Sale+OE | 5,131 | $5.74 | $29,451.94 | -13.5% | |
| Jan 17, 2023 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 782 | $5.74 | $4,488.68 | -6.6% | |
| Dec 1, 2022 | Yang Arvin | Chief Medical Officer | Sale+OE | 5,527 | $6.59 | $36,422.93 | -17.6% | |
| Aug 17, 2022 | Misra Tushar | Chief Manufacturing Officer | Sale+OE | 1,879 | $7.10 | $13,340.90 | -30.1% | |
| Jun 2, 2022 | Hack Andrew A. F.62 | Director | Buy | 95,519 | $3.27 | $311,958.27 | +0.6% | |
| May 26, 2022 | Hack Andrew A. F.62 | Director | Buy | 265,155 | $3.22 | $854,174.63 | +1.1% | |
| May 23, 2022 | Hack Andrew A. F.62 | Director | Buy | 215,599 | $3.46 | $746,437.29 | +0.9% | |
| May 18, 2022 | Hack Andrew A. F.62 | Director | Buy | 350,000 | $3.25 | $1,137,659.94 | +1.5% |